Wee1 Inhibitor AZD1775 Effectively Inhibits the Malignant Phenotypes of Esophageal Squamous Cell Carcinoma In Vitro and In Vivo
Esophageal squamous cell carcinoma (ESCC) is a common malignant diagnosed cancer with increasing incidence rate and few treatment options. As a specific small-molecule inhibitor of the Wee1 tyrosine kinase, AZD1775 has previously shown potent antitumor effect on multiple types of cancer in various p...
Main Authors: | Shuning Bi, Qiuren Wei, Zhijun Zhao, Liang Chen, Chaojie Wang, Songqiang Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00864/full |
Similar Items
-
Pharmacological Inhibition of WEE1 Potentiates the Antitumoral Effect of the <i>dl922-947</i> Oncolytic Virus in Malignant Mesothelioma Cell Lines
by: Carmelina Antonella Iannuzzi, et al.
Published: (2020-10-01) -
Recent Advances of WEE1 Inhibitors and Statins in Cancers With p53 Mutations
by: Xiangbing Meng, et al.
Published: (2021-10-01) -
Increased HDAC Activity and c-MYC Expression Mediate Acquired Resistance to WEE1 Inhibition in Acute Leukemia
by: Tamara B. Garcia, et al.
Published: (2020-03-01) -
PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer
by: Andrä Brunner, et al.
Published: (2020-07-01) -
WEE1 Inhibition Enhances Anti-Apoptotic Dependency as a Result of Premature Mitotic Entry and DNA Damage
by: Mathilde Rikje Willemijn de Jong, et al.
Published: (2019-11-01)